AGREEMENT AND PLAN OF MERGER by and among BLUEPRINT MEDICINES CORPORATION, PAVONIS MERGER SUBSIDIARY, INC., LENGO THERAPEUTICS, INC., and FORTIS ADVISORS LLC, as the Stockholders’ Representative (for the limited purposes described herein) November 27,...Merger Agreement • December 30th, 2021 • Blueprint Medicines Corp • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of November 27, 2021, by and among Blueprint Medicines Corporation, a Delaware corporation (“Buyer”), Pavonis Merger Subsidiary, Inc., a Delaware corporation and wholly-owned subsidiary of Buyer (“Merger Sub”), Lengo Therapeutics, Inc., a Delaware corporation (the “Company”), and Fortis Advisors LLC, a Delaware limited liability company, acting solely in its capacity as the representative of the Securityholders (as defined below) of the Company and only for the express purposes provided herein and for no other purpose (the “Stockholders’ Representative”).
